KefeliMYildizLCelikHTosunMKaragozF. UbcH10 expression in benign, hyperplastic, and malignant endometrial curetted materials: a tissue microarray study. Int J Surg Pathol. 2012;20:360-366.
2.
PallantePMalapelleUBerlingieriMT. UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status [published online]. Eur J Cancer. 2012. doi:10.1016/j.ejca.2012.09.033
3.
ZhaoLJiangLWangL. UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer. J Cancer Res Clin Oncol. 2012;138:1951-1961.
4.
PerrottaIBrunoLMalteseLRussoEDonatoADonatoG. Immunohistochemical analysis of the ubiquitin-conjugating enzyme UbcH10 in lung cancer: a useful tool for diagnosis and therapy. J Histochem Cytochem. 2012;60:359-365.
5.
FujitaTIkedaHKawasakiK. Clinicopathological relevance of UbcH10 in breast cancer. Cancer Sci. 2009;100:238-248.
6.
BerlingieriMTPallantePSbonerA. UbcH10 is overexpressed in malignant breast carcinomas. Eur J Cancer. 2007;43:2729-2735.
7.
ChenCCChangTWChenFM. Combination of multiple mRNA markers (PTTG1, Survivin, UbcH10 and TK1) in the diagnosis of Taiwanese patients with breast cancer by membrane array. Oncology. 2006;70:438-446.
8.
HanSSLiuQGYaoYM. UbcH10 expression in hepatocellular carcinoma and its clinicopathological significance [in Chinese]. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31:280-284.
9.
ChenSChenYHuCJingHCaoYLiuX. Association of clinicopathological features with UbcH10 expression in colorectal cancer. J Cancer Res Clin Oncol. 2010;136:419-426.
10.
ChenSMJiangCYWuJY. RNA interference-mediated silencing of UBCH10 gene inhibits colorectal cancer cell growth in vitro and in vivo. Clin Exp Pharmacol Physiol. 2010;37:525-529.
11.
FujitaTIkedaHTairaNHatohSNaitoMDoiharaH. Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer. BMC Cancer. 2009;9:87.
